Supercritical carbon dioxide-decellularized arteries exhibit physiologic-like vessel regeneration following xenotransplantation in rats. (15th February 2023)

• Record Type: Journal Article
• Authors: Sung, Shih-Ying; Lin, Yi-Wen; Wu, Chin-Chen; Lin, Chih-Yuan; Hsu, Po-Shun; Periasamy, Srinivasan; Nagarajan, Balaji; Hsieh, Dar-Jen; Tsai, Yi-Ting; Tsai, Chien-Sung; Lin, Feng-Yen
• Is Part Of: Biomaterials science. Volume 11:Number 7(2023)
• Page Start: 2566
• Page End: 2580
• Publication Date: 2023-02-15
• Subjects: Biomedical materials -- Periodicals; 610.28
• DOI: 10.1039/d2bm01233b
• Languages: English
• ISSNs: 2047-4830

Abstract

Abstract : ScCO2 -decellularized artery graft having tremendous application in vascular regenerative medicine.It with physiological-like responses, including high potential of biocompatibility and long-term patency, lower risk of aneurysm after xenotransplantation. Abstract : Currently, many techniques are used for decellularization of grafts, including physical, enzymatic, and chemical treatments. Indeed, decellularized xenogenic grafts provide superior outcomes than alternative synthetic conduits. However, vascular grafts produced by these methods are not perfect; their defects include defective vessel wall structures, detergent residues, and the development of aneurysms after grafting. Therefore, it is essential to develop a more appropriate process to produce decellularized vascular grafts. Supercritical carbon dioxide (ScCO2 ) has been used in decellularization technologies in recent years. It is beneficial for the long-term preservation of tissues and regeneration of new vessels. We have previously reported that ScCO2 -produced acellular porcine corneas show excellent biocompatibility following lamellar corneal transplantation in rabbits. In this study, we wanted to use this method to fabricate vascular grafts (ScCO2 -decellularized rabbit femoral artery (DFA)) and analyze their efficacy, parameters regarding rejection by the recipient's (ACI/NKyo rats) immune system and biocompatibility, structural regeneration, and functionality in vivo . The results indicated that the ScCO2 -DFA showed higher biocompatibility, enhanced chemotactic migration of endothelial progenitor cells, lower risk of vasculopathy, lower inflammatory and splenic immune responses, and better physiological-like tension responses after xenotransplantation (XTP) in ACI/NKyo rats compared with the results obtained after XTP using detergent decellularized vascular grafts (SDS-DFA). In conclusion, ScCO2 is an excellent decellularization technique in the fabrication of biocompatible vascular grafts and has tremendous application in vascular regenerative medicine.